Potential breakthrough for hard to treat cancers
KRAS is the most mutated gene in cancer with mutations occurring in 17%-25% of all cancers, affecting millions of patients worldwide. It plays a crucial role in tumour growth, as it is important for driving uncontrolled proliferation of tumour cells. Targeting KRAS function is a primary focus of cancer drug discovery. However, currently approved treatments … Read more
